The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: A systematic review and meta-analysis

Clinical Infectious Diseases

Volumn 42, Issue 6, 2006, Pages 788-797

  Tleyjeh, Imad M ^a,c   Tlaygeh, Haytham M ^b   Hejal, Rana ^b   Montori, Victor M ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE;

BACTEREMIA; BACTERIUM ISOLATION; CLINICAL TRIAL; COMORBIDITY; GENETIC SUSCEPTIBILITY; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LOBAR PNEUMONIA; META ANALYSIS; MORTALITY; MULTIDRUG RESISTANCE; OUTCOMES RESEARCH; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW;

AGED; COHORT STUDIES; HOSPITALIZATION; HUMANS; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMONIA, PNEUMOCOCCAL; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 33644842919     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/500140     Document Type: Review

References (31)

1. File TM. Community-acquired pneumonia. Lancet 2003; 362:1991-2001.
2. Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis. JAMA 1996; 275:134-41.
3. Felmingham D. Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT global surveillance study. Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin. J Infect 2002; 44:3-10.
4. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN, The Alexander Project G. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52:229-46.
5. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-12.
6. Aspa J, Rajas O, de Castro FR, et al. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis 2004; 38:787-98.
7. Falco V, Almirante B, Jordano Q, et al. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains? J Antimicrob Chemother 2004; 54:481-8.
8. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333:474-80.
9. Pallares R, Capdevila O, Linares J, et al. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections. Am J Med 2002; 113:120-6.
10. Sangthawan P, Chantaratchada S, Chanthadisai N, Wattanathum A. Prevalence and clinical significance of community-acquired penicillin-resistant pneumococcal pneumonia in Thailand. Respirology 2003; 8:208-12.
11. Watanabe H, Sato S, Kawakami K, et al. A comparative clinical study of pneumonia by penicillin-resistant and -sensitive Streptococcus pneumoniae in a community hospital. Respirology 2000; 5:59-64.
12. Yu VL, Chiou CCC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37:230-7.
13. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemi ology/nosgen.doc. Accessed 9 August 2005.
14. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280:1690-1.
15. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326:25.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
17. Ewig S, Ruiz M, Torres A, et al. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae. Am J Respir Crit Care Med 1999; 159:1835-42.
18. Jehl F, Bedos JP, Poirier R, Leophonte P, Sirot J, Chardon H. Nationwide survey on community-acquired pneumococcal pneumonia necessitating hospitalization [in French]. Med Mal Infect 2002; 32:267-83.
19. Song JH, Jung SI, Ki HK, et al. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian network for surveillance of resistant pathogens. Clin Infect Dis 2004; 38:1570-8.
20. Yigla M, Finkelstein R, Hashman N, Green P, Cohn L, Merzbach D. Epidemiology and clinical spectrum of pneumococcal infections: an Israeli viewpoint. J Hosp Infect 1995; 29:57-64.
21. Maugein J, Guillemot D, Dupont MJ, et al. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clin Microbiol Infect 2003; 9:280-8.
22. Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med 2004; 143:269-83.
23. Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30:520-8.
24. Azoulay-Dupuis E, Rieux V, Muffat-Joly M, et al. Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice. Antimicrob Agents Chemother 2000; 44:1575-7.
25. Levin BR. Minimizing potential resistance: a population dynamics view. Clin Infect Dis 2001; 33(Suppl 3):S161-9.
26. Nuermberger EL, Bishai WR. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis 2004; 38(Suppl 4):S363-71.
27. Metlay JP. Antibacterial drug resistance: implications for the treatment of patients with community-acquired pneumonia. Infect Dis Clin North Am 2004; 18:777-90.
28. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-9.
29. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41:327-33.
30. Besser RE. Antimicrobial prescribing in the United States: good news, bad news. Ann Intern Med 2003; 138:605-6.
31. Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance: a call for action by clinicians, public health officials, and patients. JAMA 1997; 278:944-5.